Answers are grounded in this paper and cite their sources.
Background Type 2 diabetes mellitus (T2D) is a globally prevalent metabolic epidemic with a steadily rising incidence. Selenium nanoparticles (SeNPs) exhibit exceptional antioxidant activity; however, bare SeNPs are highly susceptible to aggregation, which severely compromises their bioavailability and biological efficacy. Owing to their structural diversity and excellent biocompatibility, natural polysaccharides can effectively prevent SeNPs from aggregating while simultaneously imparting synergistic bioactivities to the resulting composites, making them ideal stabilizing carriers for SeNPs. Scope and approach This review comprehensively reviews the preparation methods, characterization techniques, and in vitro / in vivo toxicological profiles of polysaccharide-SeNPs, elucidates their gastrointestinal absorption and release mechanisms, and provides an in-depth analysis of their antidiabetic mechanisms encompassing enhancement of antioxidant defenses, activation of metabolic signaling pathways, inhibition of mitochondria dependent β cell apoptosis, and remodeling of the gut microecosystem. Key findings and conclusions Existing evidence indicates a strong synergistic relationship between the structural features of natural polysaccharides and the stability and bioactivity of SeNPs.The steric hindrance and physical encapsulation provided by polysaccharides effectively overcome the critical limitations of bare SeNPs namely their propensity for aggregation and high toxicity and enable intervention in T2D through antioxidant defense reinforcement, activation of glucose lipid metabolic pathways, and blockade of mitochondria dependent apoptosis. Furthermore, the inherent resistance of polysaccharides to digestive enzymes, coupled with their prebiotic effects, enables polysaccharide-SeNPs to remodel gut microbial homeostasis and thereby impede the pathological progression of T2D.In summary, polysaccharide-SeNPs represent a highly efficacious, controllable, and low toxicity functional material with broad application prospects in the development of hypoglycemic functional foods and adjunctive therapeutic agents.
No takes yet. Share an insight, caveat, or question.
YaoQun et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: